⌘K

Login Start Free

Home/Filings/4/0001415889-21-003146

4//SEC Filing

Walsh Angela 4

Accession 0001415889-21-003146

CIK 0001818844other

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 5:05 PM ET

Size

5.2 KB

Accession

0001415889-21-003146

Insider Transaction Report

Form 4

Period: 2021-06-21

Virios Therapeutics, Inc.VIRI

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2021-06-21+30,000→ 30,000 total
Exercise: $6.78Exp: 2031-06-21→ Common Stock (30,000 underlying)

Footnotes (1)

[F1]The stock option vests one-third on June 21, 2022 and 1/24th monthly thereafter.

Documents

1 file

4
form4-06222021_020636.xmlPrimary

Issuer

Virios Therapeutics, Inc.

CIK 0001818844

Entity typeother

Related Parties

1

filerCIK 0001825987

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 5:05 PM ET
Size: 5.2 KB

View on SEC.gov